Pharmaceutical market and health system in the Middle Eastern and Central Asian countries: Time for innovations and changes in policies and actions.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Challenge of Politico-Economic Sanctions on Pharmaceutical Procurement in Iran: A Qualitative Study.Iranian journal of medical sciences · 2022
   Article
2. Assessment of Household Disposal of Pharmaceuticals in Lebanon: Management Options to Protect Water Quality and Public Health.Environmental management · 2016
   Article
3. Consistent defined threshold and equity in health.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2015
   Article
4. A system dynamics model for national drug policy.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2014
   Article
5. Code of ethics for the national pharmaceutical system: Codifying and compilation.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2013
   Review
6. Financial perspective of private pharmacies in Tehran (Iran); is it a lucrative business?Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2012
   Article
7. Biosimilars; a unique opportunity for Iran national health sector and national pharmaceutical industry.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2012
   Article
8. Cost-effectiveness of adding-on new antiepileptic drugs to conventional regimens in controlling intractable seizures in children.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2012
   Article
9. A model for developing a decision support system to simulate national drug policy indicators.Archives of medical science : AMS · 2011
   Article
10. A news media analysis of economic sanction effects on access to medicine in Iran.Journal of research in pharmacy practice
    Article
11. Trend Analysis of Medicine Consumption Based on Therapeutic Categories in Iran: 2000-2016.Journal of research in pharmacy practice
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.